Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...

Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...

Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...

PFS in Phase 3 HARMONi study was met with statistical significance, but OS was not. Click here to find out why SMMT stock is ...

Survival rates among breast cancer patients whose cancer is detected before it spreads are high, between 86% and 89%. Yet if ...

Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...

There’s a worrying trend in the cancer world with young adults getting cancer at higher rates, and scientists don’t know why.

Drugmakers are turning to biomarkers, like folate receptor alpha, and even cell therapies to tackle this deadly cancer in new ...

Scientists at St. Jude Children's Research Hospital have found that genetics and type of cancer treatment contribute most to ...

Bob Segert is the chairman and CEO of athenahealth, a technology company offering electronic health records, revenue cycle ...